Dominique Mouraux1, Eric Brassinne1, Stéphane Sobczak1,2,3, Antoine Nonclercq4, Nadine Warzée5, Phillip S Sizer3, Turgay Tuna6, Benoît Penelle5. 1. Department of Physical Therapy and Rehabilitation, Hôpital Erasme, Université libre de Bruxelles, ULB, Bruxelles, Belgium. 2. Département d'anatomie, Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada. 3. Department of Rehabilitation Sciences, Center for Rehabilitation Research, School of Health Professions, Texas Tech University Health Sciences Center, Lubbock, TX, USA. 4. Belgium BEAMS Department - Bio, Electro and Mechanical Systems, Université libre de Bruxelles, ULB, Bruxelles, Belgium. 5. LISA Laboratory, Université libre de Bruxelles, ULB, Bruxelles, Belgium. 6. Department of Anaesthesiology, Pain Clinic, Hôpital Erasme, Université libre de Bruxelles, ULB, Bruxelles, Belgium.
Abstract
Objective: We assessed whether or not pain relief could be achieved with a new system that combines 3D augmented reality system (3DARS) and the principles of mirror visual feedback. Methods: Twenty-two patients between 18 and 75 years of age who suffered of chronic neuropathic pain. Each patient performed five 3DARS sessions treatment of 20 mins spread over a period of one week. The following pain parameters were assessed: (1) visual analogic scale after each treatment session (2) McGill pain scale and DN4 questionnaire were completed before the first session and 24 h after the last session. Results: The mean improvement of VAS per session was 29% (p < 0.001). There was an immediate session effect demonstrating a systematic improvement in pain between the beginning and the end of each session. We noted that this pain reduction was partially preserved until the next session. If we compare the pain level at baseline and 24 h after the last session, there was a significant decrease (p < 0.001) of pain of 37%. There was a significant decrease (p < 0.001) on the McGill Pain Questionnaire and DN4 questionnaire (p < 0.01). Conclusion: Our results indicate that 3DARS induced a significant pain decrease for patients who presented chronic neuropathic pain in a unilateral upper extremity. While further research is necessary before definitive conclusions can be drawn, clinicians could implement the approach as a preparatory adjunct for providing temporary pain relief aimed at enhancing chronic pain patients' tolerance of manual therapy and exercise intervention. Level of Evidence: 4.
Objective: We assessed whether or not pain relief could be achieved with a new system that combines 3D augmented reality system (3DARS) and the principles of mirror visual feedback. Methods: Twenty-two patients between 18 and 75 years of age who suffered of chronic neuropathic pain. Each patient performed five 3DARS sessions treatment of 20 mins spread over a period of one week. The following pain parameters were assessed: (1) visual analogic scale after each treatment session (2) McGill pain scale and DN4 questionnaire were completed before the first session and 24 h after the last session. Results: The mean improvement of VAS per session was 29% (p < 0.001). There was an immediate session effect demonstrating a systematic improvement in pain between the beginning and the end of each session. We noted that this pain reduction was partially preserved until the next session. If we compare the pain level at baseline and 24 h after the last session, there was a significant decrease (p < 0.001) of pain of 37%. There was a significant decrease (p < 0.001) on the McGill Pain Questionnaire and DN4 questionnaire (p < 0.01). Conclusion: Our results indicate that 3DARS induced a significant pain decrease for patients who presented chronic neuropathic pain in a unilateral upper extremity. While further research is necessary before definitive conclusions can be drawn, clinicians could implement the approach as a preparatory adjunct for providing temporary pain relief aimed at enhancing chronic painpatients' tolerance of manual therapy and exercise intervention. Level of Evidence: 4.
Authors: R Norman Harden; Stephen Bruehl; Roberto S G M Perez; Frank Birklein; Johan Marinus; Christian Maihofner; Timothy Lubenow; Asokumar Buvanendran; Sean Mackey; Joseph Graciosa; Mila Mogilevski; Christopher Ramsden; Tanja Schlereth; Melissa Chont; Jean-Jacques Vatine Journal: Pain Date: 2010-10-20 Impact factor: 6.961
Authors: Francis J Keefe; Dane A Huling; Michael J Coggins; Daniel F Keefe; Zachary M Rosenthal; Nathaniel R Herr; Hunter G Hoffman Journal: Pain Date: 2012-07-04 Impact factor: 6.961
Authors: Hunter G Hoffman; David R Patterson; Eric Seibel; Maryam Soltani; Laura Jewett-Leahy; Sam R Sharar Journal: Clin J Pain Date: 2008-05 Impact factor: 3.442
Authors: Craig D Murray; Stephen Pettifer; Toby Howard; Emma L Patchick; Fabrice Caillette; Jai Kulkarni; Candy Bamford Journal: Disabil Rehabil Date: 2007-09-30 Impact factor: 3.033
Authors: Nadine S Matthie; Nicholas A Giordano; Coretta M Jenerette; Gayenell S Magwood; Sharon L Leslie; Emily E Northey; Caitlin I Webster; Soumitri Sil Journal: Pain Manag Date: 2022-09-13
Authors: Lisa Goudman; Julie Jansen; Maxime Billot; Nieke Vets; Ann De Smedt; Manuel Roulaud; Philippe Rigoard; Maarten Moens Journal: JMIR Serious Games Date: 2022-05-10 Impact factor: 3.364